During the past decade, Ospedale Civile di Legnano conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile di Legnano" #1 sponsor was "Fadoi Foundation, Italy" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "National Cancer Institute, Naples" with 2 trials sponsored, "Società Italiana di Cardiologia Invasiva" with 2 trials sponsored and "ASST Fatebenefratelli Sacco" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile di Legnano" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Cordis Italy a division of Johnson & Johnson Medical SpA" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile di Legnano" are "Myocardial Infarction" (2 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials), "Adverse Drug Event" (1 trials) and "Aortic Stenosis" (1 trials). Many other conditions were trialed in "Ospedale Civile di Legnano" in a lesser frequency.

Most popular intervention types in "Ospedale Civile di Legnano" are "Drug" (14 trials), "Device" (6 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Cisplatin" (2 trials), "Placebo" (2 trials), "cisplatin" (2 trials) and "gemcitabine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile di Legnano" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile di Legnano". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ospedale Civile di Legnano, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile di Legnano, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Ospedale Civile di Legnano has several departments that took part in Clinical trials: "Ospedale Civile - Uo Cardiologia" - 5 trials, "Ospedale Civile Fornaroli, U.O. Cardiologia" - 3 trials, "ASST OVEST MILANESE; Oncologia Medica" - 2 trials